KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Payables (2016 - 2025)

Humana (HUM) has disclosed Payables for 16 consecutive years, with $6.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Payables changed N/A to $6.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $6.0 billion, a N/A change, with the full-year FY2025 number at $6.0 billion, changed N/A from a year prior.
  • Payables was $6.0 billion for Q4 2025 at Humana, up from $5.8 billion in the prior quarter.
  • In the past five years, Payables ranged from a high of $8.6 billion in Q2 2023 to a low of $4.8 billion in Q4 2021.
  • A 4-year average of $6.2 billion and a median of $5.9 billion in 2025 define the central range for Payables.
  • Peak YoY movement for Payables: dropped 20.83% in 2021, then soared 38.8% in 2023.
  • Humana's Payables stood at $4.8 billion in 2021, then increased by 14.5% to $5.5 billion in 2022, then skyrocketed by 41.73% to $7.8 billion in 2023, then fell by 23.23% to $6.0 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Payables are $6.0 billion (Q4 2025), $5.8 billion (Q3 2025), and $5.9 billion (Q2 2025).